Literature DB >> 12720447

In vitro evolution of an RNA-cleaving DNA enzyme into an RNA ligase switches the selectivity from 3'-5' to 2'-5'.

Amber Flynn-Charlebois1, Tracey K Prior, Kelly A Hoadley, Scott K Silverman.   

Abstract

Deoxyribozymes that ligate RNA expand the scope of nucleic acid catalysis and allow preparation of site-specifically modified RNAs. Previously, deoxyribozymes that join a 5'-hydroxyl and a 2',3'-cyclic phosphate were identified by in vitro selection from random DNA pools. Here, the alternative strategy of in vitro evolution was used to transform the 8-17 deoxyribozyme that cleaves RNA into a family of DNA enzymes that ligate RNA. The parent 8-17 DNA enzyme cleaves native 3'-5' phosphodiester linkages but not 2'-5' bonds. Surprisingly, the new deoxyribozymes evolved from 8-17 create only 2'-5' linkages. Thus, reversing the direction of the DNA-mediated process from ligation to cleavage also switches the selectivity in forming the new phosphodiester bond. The same change in selectivity was observed upon evolution of the 10-23 RNA-cleaving deoxyribozyme into an RNA ligase. The DNA enzymes previously isolated from random pools also create 2'-5' linkages. Therefore, deoxyribozyme-mediated formation of a non-native 2'-5' phosphodiester linkage from a 5'-hydroxyl and a 2',3'-cyclic phosphate is strongly favored in many different contexts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12720447     DOI: 10.1021/ja0340331

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  15 in total

1.  Functional compromises among pH tolerance, site specificity, and sequence tolerance for a DNA-hydrolyzing deoxyribozyme.

Authors:  Ying Xiao; Madhavaiah Chandra; Scott K Silverman
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

2.  DNA-catalyzed covalent modification of amino acid side chains in tethered and free peptide substrates.

Authors:  On Yi Wong; P I Pradeepkumar; Scott K Silverman
Journal:  Biochemistry       Date:  2011-05-03       Impact factor: 3.162

3.  Zn2+-dependent deoxyribozymes that form natural and unnatural RNA linkages.

Authors:  Kelly A Hoadley; Whitney E Purtha; Amanda C Wolf; Amber Flynn-Charlebois; Scott K Silverman
Journal:  Biochemistry       Date:  2005-06-28       Impact factor: 3.162

4.  Strand-specific (asymmetric) contribution of phosphodiester linkages on RNA polymerase II transcriptional efficiency and fidelity.

Authors:  Liang Xu; Lu Zhang; Jenny Chong; Jun Xu; Xuhui Huang; Dong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-29       Impact factor: 11.205

5.  Parallel selections in vitro reveal a preference for 2'-5' RNA ligation upon deoxyribozyme-mediated opening of a 2',3'-cyclic phosphate.

Authors:  Daniel R Semlow; Scott K Silverman
Journal:  J Mol Evol       Date:  2005-06-30       Impact factor: 2.395

Review 6.  Deoxyribozymes: selection design and serendipity in the development of DNA catalysts.

Authors:  Scott K Silverman
Journal:  Acc Chem Res       Date:  2009-10-20       Impact factor: 22.384

7.  Kinetic and thermodynamic characterization of the RNA-cleaving 8-17 deoxyribozyme.

Authors:  Maria Bonaccio; Alfredo Credali; Alessio Peracchi
Journal:  Nucleic Acids Res       Date:  2004-02-12       Impact factor: 16.971

8.  Structure-function correlations derived from faster variants of a RNA ligase deoxyribozyme.

Authors:  Tracey K Prior; Daniel R Semlow; Amber Flynn-Charlebois; Imran Rashid; Scott K Silverman
Journal:  Nucleic Acids Res       Date:  2004-02-11       Impact factor: 16.971

9.  Controlling the direction of site-selectivity and regioselectivity in RNA ligation by Zn2+-dependent deoxyribozymes that use 2',3'-cyclic phosphate RNA substrates.

Authors:  Diana M Kost; Joseph P Gerdt; P I Pradeepkumar; Scott K Silverman
Journal:  Org Biomol Chem       Date:  2008-10-27       Impact factor: 3.876

10.  Systematic analysis of the role of target site accessibility in the activity of DNA enzymes.

Authors:  Graeme Doran; Muhammad Sohail
Journal:  J RNAi Gene Silencing       Date:  2006-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.